Skip to main content
. 2021 Dec 1;45(2):311–318. doi: 10.2337/dc21-0944

Figure 3.

Figure 3

Cumulative incidence curves for progression to clinical disease within each group. HI-IND60 and HI-BOTH aggregated with higher cumulative incidence than HI-2HGLU or LO-BOTH. *P < 0.001 compared with HI-2HGLU and LO-BOTH. T1D, type 1 diabetes.